Суикс Биофарма ЕООД
A United Kingdom supplier, with 1 awarded contract, totalling £1.5m, most recently 14 months ago.
This contract involves the supply of a pharmaceutical product with the International Nonproprietary Name (INN) Olipudase alfa, at a dosage of 20 mg. This product is listed under Article 266a, paragraph 2 of the Bulgarian Law on Medicinal Products. The contract is published by the Specialized Hospita
